Zanele Makhado
Johannesburg, GT, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Defining the mechanism of cross-reactivity for a SARS-CoV-2 Beta-elicited antibody toward omicron sub-lineages.
Journal: Structure (London, England : 1993)
Published: September 29, 2025
Monitoring broadly neutralising HIV antibody concentrations using microsampling on dried blood spots in infants.
Journal: The Journal of infection
Published: April 07, 2025
SARS-CoV-2 vaccines elicit differential Fc effector functions.
Journal: iScience
Published: January 15, 2025
Population shift in antibody immunity following the emergence of a SARS-CoV-2 variant of concern.
Journal: Scientific reports
Published: November 13, 2024
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.
Journal: PLOS global public health
Published: December 04, 2023
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.
Journal: medRxiv : the preprint server for health sciences
Published: December 04, 2023
Comparing the immune abnormalities in MIS-C to healthy children and those with inflammatory disease reveals distinct inflammatory cytokine production and a monofunctional T cell response.
Journal: Clinical immunology (Orlando, Fla.)
Published: September 04, 2023
Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation.
Journal: Nature communications
Published: August 10, 2023
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection.
Journal: PLoS pathogens
Published: June 07, 2023
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination.
Journal: Frontiers in immunology
Published: May 30, 2023
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection.
Journal: medRxiv : the preprint server for health sciences
Published: March 30, 2023
Last Updated: 09/26/2026